Compare Immune Targeting Systems vs Iomai Corporation
Customers evaluate the quality of Immune Targeting Systems's products using the following success metrics.
Overview
Immune Targeting Systems is 21 yrs old and is based in United Kingdom.
Immune Targeting System is a London based vaccine company developing vaccines for mutating viruses. The company's synthetic T cell platform aims to allow to develop vaccines for the prevention and treatment of major life-threatening viral infections of global impact, including pandemic and seasonal influenza.
Iomai Corporation is 27 yrs old and is based in United States.
Iomai Corporation is developing vaccines and immune system stimulants delivered through needle-free transcutaneous immunization
Demo Video
Leadership
Michael McNamara (Chief Financial Officer)
Stanley C Erck (Chief Executive Officer, President)
Investors
Altimmune, HealthCap Venture Capital
Intercell, New Enterprise Associates
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Immune Targeting Systems has not claimed their profile.
Work for Immune Targeting Systems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Immune Targeting Systems?
Claim your profile now.
Information not available because Iomai Corporation has not claimed their profile.
Work for Iomai Corporation? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Iomai Corporation?
Claim your profile now.